Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19.
World J Virol
; 11(1): 82-84, 2022 Jan 25.
Article
in English
| MEDLINE | ID: covidwho-1675117
ABSTRACT
Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the severity of the disease, or improves the outcome. Appropriately designed clinical trials are warranted to prove or disprove a therapeutic effect of NAC for COVID-19 patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
World J Virol
Year:
2022
Document Type:
Article
Affiliation country:
Wjv.v11.i1.82
Similar
MEDLINE
...
LILACS
LIS